Matches in SemOpenAlex for { <https://semopenalex.org/work/W2102273744> ?p ?o ?g. }
- W2102273744 endingPage "2038" @default.
- W2102273744 startingPage "2032" @default.
- W2102273744 abstract "To assess the effect of fibric acid derivative bezafibrate on incidence of type 2 diabetes in obese patients over a median 6.3 years follow-up period.The study sample comprised 339 non-diabetic obese patients (body mass index > or = 30.0 kg/m2) aged 42-74. Patients received either bezafibrate retard 400 mg (178 patients) or placebo (161 patients) once daily. Development of new diabetes was recorded in 98 patients: in 56 (37.0%) from the placebo group vs. 42 (27.1%) from the bezafibrate group, (P log-rank=0.01). The median time (interquartile range) until onset of new diabetes was significantly delayed in patients on bezafibrate when compared with those on placebo: 4.0 (2.1-5.0) vs. 2.0 (0.5-3.5) years, P=0.002. Multivariable analysis identified bezafibrate treatment as an independent predictor of reduced risk of new diabetes with hazard ratio (HR) 0.59 [95% confidence interval (CI) 0.39-0.91]. Other significant variables associated with future overt type 2 diabetes in obese patients were triglycerides (50 mg/dL increment) with HR 1.15 (95% CI 1.02-1.28) and fasting glucose (10 mg/dL increment) with HR 2.27 (95% CI 1.83-2.81).Bezafibrate, when compared with placebo, reduced the incidence and delayed the onset of type 2 diabetes in obese patients over a long-term follow-up period." @default.
- W2102273744 created "2016-06-24" @default.
- W2102273744 creator A5004886183 @default.
- W2102273744 creator A5018210928 @default.
- W2102273744 creator A5024658913 @default.
- W2102273744 creator A5028734680 @default.
- W2102273744 creator A5037425168 @default.
- W2102273744 creator A5046330272 @default.
- W2102273744 creator A5066402379 @default.
- W2102273744 creator A5067030113 @default.
- W2102273744 creator A5067683880 @default.
- W2102273744 creator A5088855810 @default.
- W2102273744 date "2005-05-04" @default.
- W2102273744 modified "2023-10-14" @default.
- W2102273744 title "Effect of bezafibrate on incidence of type 2 diabetes mellitus in obese patients" @default.
- W2102273744 cites W1964732931 @default.
- W2102273744 cites W1970298287 @default.
- W2102273744 cites W1974548284 @default.
- W2102273744 cites W1977666051 @default.
- W2102273744 cites W1996595996 @default.
- W2102273744 cites W2011871953 @default.
- W2102273744 cites W2023597944 @default.
- W2102273744 cites W2037727132 @default.
- W2102273744 cites W2046889389 @default.
- W2102273744 cites W2048619296 @default.
- W2102273744 cites W2060209571 @default.
- W2102273744 cites W2060449981 @default.
- W2102273744 cites W2061489988 @default.
- W2102273744 cites W2064535286 @default.
- W2102273744 cites W2065876677 @default.
- W2102273744 cites W2078807483 @default.
- W2102273744 cites W2087122397 @default.
- W2102273744 cites W2096346573 @default.
- W2102273744 cites W2096773810 @default.
- W2102273744 cites W2104094771 @default.
- W2102273744 cites W2110305332 @default.
- W2102273744 cites W2113328569 @default.
- W2102273744 cites W2121200936 @default.
- W2102273744 cites W2123289485 @default.
- W2102273744 cites W2123744385 @default.
- W2102273744 cites W2126327417 @default.
- W2102273744 cites W2135723092 @default.
- W2102273744 cites W2137936645 @default.
- W2102273744 cites W2138130607 @default.
- W2102273744 cites W2139698840 @default.
- W2102273744 cites W2146536851 @default.
- W2102273744 cites W2147098206 @default.
- W2102273744 cites W2152789823 @default.
- W2102273744 cites W2157135485 @default.
- W2102273744 cites W2158103150 @default.
- W2102273744 cites W2158822657 @default.
- W2102273744 cites W2170378756 @default.
- W2102273744 cites W2332951586 @default.
- W2102273744 cites W2334103991 @default.
- W2102273744 cites W2400712338 @default.
- W2102273744 cites W4229737217 @default.
- W2102273744 cites W4233562854 @default.
- W2102273744 cites W424467158 @default.
- W2102273744 cites W4361972733 @default.
- W2102273744 cites W91098912 @default.
- W2102273744 doi "https://doi.org/10.1093/eurheartj/ehi310" @default.
- W2102273744 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15872029" @default.
- W2102273744 hasPublicationYear "2005" @default.
- W2102273744 type Work @default.
- W2102273744 sameAs 2102273744 @default.
- W2102273744 citedByCount "78" @default.
- W2102273744 countsByYear W21022737442012 @default.
- W2102273744 countsByYear W21022737442013 @default.
- W2102273744 countsByYear W21022737442014 @default.
- W2102273744 countsByYear W21022737442015 @default.
- W2102273744 countsByYear W21022737442017 @default.
- W2102273744 countsByYear W21022737442018 @default.
- W2102273744 countsByYear W21022737442019 @default.
- W2102273744 countsByYear W21022737442020 @default.
- W2102273744 countsByYear W21022737442022 @default.
- W2102273744 countsByYear W21022737442023 @default.
- W2102273744 crossrefType "journal-article" @default.
- W2102273744 hasAuthorship W2102273744A5004886183 @default.
- W2102273744 hasAuthorship W2102273744A5018210928 @default.
- W2102273744 hasAuthorship W2102273744A5024658913 @default.
- W2102273744 hasAuthorship W2102273744A5028734680 @default.
- W2102273744 hasAuthorship W2102273744A5037425168 @default.
- W2102273744 hasAuthorship W2102273744A5046330272 @default.
- W2102273744 hasAuthorship W2102273744A5066402379 @default.
- W2102273744 hasAuthorship W2102273744A5067030113 @default.
- W2102273744 hasAuthorship W2102273744A5067683880 @default.
- W2102273744 hasAuthorship W2102273744A5088855810 @default.
- W2102273744 hasBestOaLocation W21022737441 @default.
- W2102273744 hasConcept C119060515 @default.
- W2102273744 hasConcept C120665830 @default.
- W2102273744 hasConcept C121332964 @default.
- W2102273744 hasConcept C126322002 @default.
- W2102273744 hasConcept C134018914 @default.
- W2102273744 hasConcept C142724271 @default.
- W2102273744 hasConcept C204787440 @default.
- W2102273744 hasConcept C207103383 @default.
- W2102273744 hasConcept C27081682 @default.
- W2102273744 hasConcept C2776362216 @default.